(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMABLOCK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMABLOCK

ST13

US500000085623516

Class

5

Filing

85623516

Registration

4264494

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

06/29/2023

Trademark type

Word

Nice classes

5

Filing date

05/11/2012

Registration date

12/25/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2023

Last transaction

06/29/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

01/01/2007

First use in commerce

01/01/2008

Drawing code

4

Owner type

03

Owner location

Hatfield, PA

Examiner

WOOD, CAROLINE

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Pharmablock USA, Inc
Pharmablock USA, Inc

Representatives

Pharmablock USA, Inc

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for pharmaceutical or medical purposesfor the treatment of cancerCNSinflammationmetaboliccardiovascularrespiratoryinfectious diseases

Publications

History of USPTO decisions and trademark events.

21 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/29/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/29/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/29/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/29/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

11/30/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/25/2021

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/31/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/31/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/31/2018

ES8R

TEAS SECTION 8 RECEIVED

03/22/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/22/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/25/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

12/25/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/09/2012

PUBO

PUBLISHED FOR OPPOSITION

10/09/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/19/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/05/2012

DOCK

ASSIGNED TO EXAMINER

09/03/2012

MPMK

NOTICE OF PSEUDO MARK MAILED

05/18/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/17/2012

NWAP

NEW APPLICATION ENTERED

05/15/2012

Continuous trademark protection

Get notified about every new filing that threatens PHARMABLOCK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.